Insider · CIK 0001755495

Vera Juan

Reports to the SEC for 2 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001755495

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-31	MRKRMarker Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2025-02-12	MRKRMarker Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	50,000
2024-06-06	KLRSKalaris Therapeutics, Inc.A Award	Director	AAward	+35K sh	—	—	2,409,928
2023-05-11	KLRSKalaris Therapeutics, Inc.A Award	Director	AAward	+35K sh	—	—	2,374,928
2023-05-10	MRKRMarker Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2023-02-27	MRKRMarker Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+46.5K sh	—	—	46,487
2022-05-17	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2022-03-24	MRKRMarker Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+141K sh	—	—	2,705,310
2022-03-24	MRKRMarker Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−33.5K sh	$0.48	−$16.2K	2,671,845
2022-02-17	MRKRMarker Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+160K sh	—	—	160,000
2021-05-25	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2021-03-16	MRKRMarker Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+571K sh	$1.75	+$1M	2,564,487
2021-03-03	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−1,300 sh	$37.01	−$48.1K	2,354,616
2021-03-03	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−7,142 sh	$38.22	−$273K	2,347,474
2021-03-03	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−7,546 sh	$38.63	−$292K	2,339,928
2021-03-02	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−4,190 sh	$37.28	−$156K	2,366,720
2021-03-02	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−9,001 sh	$38.30	−$345K	2,357,719
2021-03-02	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−1,803 sh	$39.10	−$70.5K	2,355,916
2021-03-01	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−11.6K sh	$38.27	−$443K	2,392,194
2021-03-01	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−20.6K sh	$38.73	−$797K	2,371,610
2021-03-01	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−700 sh	$39.53	−$27.7K	2,370,910
2021-02-23	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−1,125 sh	$38.33	−$43.1K	2,411,489
2021-02-23	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−4,825 sh	$39.11	−$189K	2,406,664
2021-02-23	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−2,300 sh	$40.13	−$92.3K	2,404,364
2021-02-23	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−600 sh	$40.97	−$24.6K	2,403,764
2021-02-22	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−2,891 sh	$41.58	−$120K	2,424,044
2021-02-22	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−11.1K sh	$42.80	−$473K	2,412,994
2021-02-22	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−380 sh	$43.40	−$16.5K	2,412,614
2021-02-19	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−13.2K sh	$41.79	−$553K	2,426,935
2021-02-18	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−1,200 sh	$39.48	−$47.4K	2,447,910
2021-02-18	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−4,032 sh	$40.44	−$163K	2,443,878
2021-02-18	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−3,710 sh	$41.49	−$154K	2,440,168
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$38.71	−$77.4K	2,454,570
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−1,400 sh	$40.00	−$56K	2,453,170
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−4,060 sh	$41.26	−$168K	2,449,110
2021-02-16	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−9,434 sh	$41.79	−$394K	2,457,536
2021-02-16	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−966 sh	$42.53	−$41.1K	2,456,570
2021-02-10	MRKRMarker Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+140K sh	—	—	140,000
2020-08-03	KLRSKalaris Therapeutics, Inc.C Conversion	Director	CConversion	+2.44M sh	—	—	2,466,970
2020-08-03	KLRSKalaris Therapeutics, Inc. · Series A-3 Convertible Preferred StockC Conversion	Director	CConversion	−3.63M sh	—	—	0
2020-07-29	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2020-03-10	MRKRMarker Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+26.6K sh	—	—	26,600
2020-03-10	MRKRMarker Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+113K sh	—	—	113,400
2018-10-19	MRKRMarker Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000

Recent filings

Accepted (ET)
Nov 44
Vera Juan0001755495-25-000003
SEC(opens sec.gov)
Feb 144
Vera Juan0001104659-25-014315
SEC(opens sec.gov)
Jun 74
Vera Juan0000950170-24-070597
SEC(opens sec.gov)
May 124
Vera Juan0001209191-23-029099
SEC(opens sec.gov)
May 114
Vera Juan0001209191-23-028846
SEC(opens sec.gov)
Mar 14
Vera Juan0001209191-23-014158
SEC(opens sec.gov)
May 194
Vera Juan0000899243-22-018820
SEC(opens sec.gov)
Mar 284
Vera Juan0001209191-22-021395
SEC(opens sec.gov)
Feb 224
Vera Juan0001209191-22-011787
SEC(opens sec.gov)
May 274
Vera Juan0000899243-21-020862
SEC(opens sec.gov)
Mar 184
Vera Juan0001209191-21-021773
SEC(opens sec.gov)
Mar 34
Vera Juan0001209191-21-017536
SEC(opens sec.gov)

Companies

Address

C/O MARKER THERAPEUTICS, INC., 2450 HOLCOMBE BLVD, SUITE BCM-A, MS: BCM251

HOUSTON, TX, 77021